Dr. Phillip Chan, Chief Executive Officer, and Peter J. Mariani, Chief Financial Officer, will participate in one-on-one investor meetings on Wednesday, December 4, 2024.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Peripheral Arterial Disease ...

Low serum trough concentrations and high vancomycin minimum inhibitory concentration in methicillin-sensitive staphylococcus aureus from hemodialysis patients in Brazil. Ther Drug Monit. 2019;41:38-43 ...

Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Welcome to the Talphera Third Quarter 2024 Financial Results Conference Call. This call is being webcast live via the Events page of the ...

Dialysis patients with atrial fibrillation ... Can Apixaban Be a Better Option Than Warfarin for Atrial Fibrillation Patients? Anticoagulant drug apixaban found to be more superior than warfarin ...

In one of the largest studies of its kind, researchers analyzed data from more than 500,000 patients undergoing dialysis in the United States and found that women have a higher risk of heart ...

Werring DJ, Dehbi HM, Ahmed N, et al., on behalf of the OPTIMAS investigators. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): a multicenter, ...

[Image courtesy of Quanta Dialysis Technologies] Quanta Dialysis Technologies announced today that it received FDA 510(k) clearance for the use of its dialysis system in the home. Beverly ...

compared to anticoagulation (AC), catheter-directed thrombolysis (CDT), or other mechanical thrombectomy (MT) in the United States. Parag J. Patel, MD, presented the findings in the second ...

Therefore, similar to monitoring the circuit calcium for effective extracorporeal anticoagulation, monitoring of the patient's iCa is performed every hour until a steady state of removal has been ...